Artixio

Pharmaceutical Regulatory Affairs in Qatar

Artixio covers all, from the early stage regulatory strategy to product registration globally, efficient regulatory operations and then post marketing maintenance in Qatar.

Regulatory Affairs Consulting for Pharmaceuticals in Qatar

Artixio has established collaborations with 50+ global pharmaceutical firms, providing successful market entries and regulatory approvals for a wide range of products. We have a team of experts with more than 30 years of experience with respect to Qatar’s regulatory framework and has delivered high impact solutions to multiple therapeutic areas and innovations.

We provide support from early stage development via product registration to post approval support. W provide integrated and comprehensive regulatory solutions using regulatory intelligence. Our services include strategic consulting, regulatory writing, dossier preparation, electronic publishing, labelling and artwork management, promotional material review, and regulatory information management.

Pharma Regulatory Authorities in Qatar:

Regulatory Body Role
Ministry of Public Health (MOPH) Monitors all regulations related to health, including pharmaceutical products.
Qatar Drug Control Department (DCD) Responsible for drug registration, distribution, and licensing of pharmaceutical products.
Qatar Standards Organization (QSO) Ensures compliance with quality standards for imported pharmaceutical products.

Pharmaceutical Regulations in Qatar (MoPH)

The central regulatory body of Qatar is Qatar Ministry of Public Health (MoPH) which regulates the process of drug registration and approval. It ensures that all the products meet the standards for efficacy, safety and quality.

Major requirements

The applicant must fulfil these major requirements for submitting a drug product application-

  • Valid and legal Good Manufacturing Practice (GMP) certificate from the origin country’s health authority.
  • Valid and legal manufacturing license (ML) from the origin country’s health authority.
  • A relationship letter between the MAH and manufacturer
  • The product list which are manufactured by the manufacturer listing their trade and generic names and pharmacological groups.
  • Site master file copy
  • If available, then certificate of registration of the manufacturing sit in gulf countries.

Regulatory Process

The applicant must fulfil these major requirements for submitting a drug product application-

  • The application is submitted through online portal PDCD E-system.

  • The application is then assessed and for any further requirements the local agent is informed.

  • The file is then presented to the registration committee and the decision is notified to the local agent.

  • If the decision is positive, then the registration certificate is generated online on the official website.

Pharma Regulatory Affairs Services in Qatar

Artixio offers a range of regulatory affairs solutions in Qatar to assist pharmaceutical companies with product registration:

Regulatory Affairs Process for Pharmaceuticals in Qatar (MoPH)

Registration Process for Pharmaceuticals in Qatar (MoPH)
The registration application must include the below mentioned information: –

Market Authorization Holder responsibilities

  • Ensuring safety, efficacy and quality of the product throughout its lifecycle.
  • Preparation of the dossier in eCTD format.
  • If any product variation is there they have to inform the PDCD.

Local agent role

  • They have to handle the communications from MoPH.
  • The person or company must be a Qatari registered organization meeting all the requirements of MoPH.
  • Responsible for the registration of MAH and the manufacturing site before the submission of the application.

Process for submission

  • All the applications have to be submitted through PDCD system.

New product registration

Online Filling of Application

  • The applicant should be complete and submitted through the PDCD E-system.
  • Firstly, the application has to go through the preliminary review and then for file submission.

Acceptance for the submission

  • The applicant has to submit all the required documents. The authority will check that all the requirements are met and proceed for the review.

Review phase

  • The application will go through the assessment. If any query arrives it will be notified to the applicant through the local agent.
  • If the PDCD requirements are not met within 4 months, the application will be rejected automatically.

Application acceptance

  • After the validation, assessment and if all the MoPH requirements are met then the file will be submitted to committee and they will give the decision.

Labelling requirements

  • The compliance should be there with Qatari labelling and packaging requirements.
  • All the information regarding the drug’s packaging, dosage, warnings and expiry date.

Why Artixio for Pharmaceutical Regulatory Affairs in Qatar

Strong Regional Expert with 30+ years of experience  
Successful Approvals and Product Lifecycle Maintenance for 300+ products 
Proven Experience in End-to-End Product Value Chain from Concept to Commercialization  
Deep knowledge of Qatari regulatory bodies, ensuring compliance.
Local experts for direct communication with Qatari authorities.
ISO 9001:2015 quality standards governed services   

FAQs

What is the timeline for the registration certificate?

The registration certificate is valid only for 5 years. The renewal request must be submitted before 6 months from the date of expiry.

PDCD IN Qatar provides fast track review for the new products already registered in GCC. This process generally eliminates the full evaluation of the application but some requirements should be met.

  • A valid GCC registration certificate must be there.
  • Any variations after the registration during initial period must be submitted.
Yes, Qatar requires a local legal agent or representative for pharmaceutical product registration. Artixio can assist with appointing the right local representation to handle the registration process.

Still Have Questions ?

Get expert answers tailored to your needs.

Specialized Regulatory Affairs
Services Across Multiple Industries

Pharmaceuticals

MedTech

Cosmetics

Nutrition

Biologics

Veterinary

Expert Regulatory Services To Streamline Compliance

Regulatory Intelligence & Strategy
Medical & Technical Writing
Publishing & Submission
Product Registration
Investigation New Drug Application (IND)
New Drug Application (NDA)
Post Approval Lifecycle Maintenance
Artwork and Label Review
Ad Promo Review

Regulatory Affairs Across Multiple Countries

India

Singapore

Mexico

Brazil

Vietnam

Malaysia

Argentina

Colombia

Taiwan

China

China

Thailand

Indonesia

Philippines

USA

Japan

Qatar

South Korea

Insights from Artixio - Tips & Articles

In Vitro Diagnostics: Meaning, Types And Benefits

In Vitro Diagnostics: Meaning,

The term “in vitro” is a Latin word that means “in glass”. Thus, from...

June 20, 2025
IVD Medical Devices Registration & Approval In India

IVD Medical Devices Registration

The in vitro diagnostic in India is regulated by the Central Drugs Standard Control...

June 17, 2025
Pharma Manufacturing Booms in Hidalgo, Mexico

Pharma Manufacturing Booms in

Once overlooked pharma hub in Mexico's Hidalgo region has gained importance with global market...

June 18, 2025